FDA Approves Ziopta for Lowering IOP

The Food and Drug Administration (FDA) approved Ziopta (tafluprost ophthalmic solution) 0.0015%, the first preservative-free prostaglandin analog ophthalmic solution. Zioptan is approved for reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension. Read more.